← Back to Search

Imaging

CT Coronary Angiogram with quantitative characterization of plaque for Coronary Artery Disease

N/A
Recruiting
Led By Damini Dey, PhD
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights

Study Summary

This trial will compare the effectiveness of intensive medical therapy vs usual care in reducing plaque buildup and improving clinical symptoms in women with no major blockages in their arteries.

Eligible Conditions
  • Coronary Artery Disease
  • Ischemia
  • Coronary Atherosclerosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in angina score assessed by the Seattle Angina Questionnaire (SAQ)
Change in atherosclerotic plaque burden and noncalcified plaque composition
Change in coronary plaque inflammation (measured as CT attenuation of Pericoronary adipose tissue)

Trial Design

1Treatment groups
Experimental Treatment
Group I: CT Coronary Angiogram with quantitative characterization of plaqueExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Cedars-Sinai Medical CenterLead Sponsor
500 Previous Clinical Trials
164,659 Total Patients Enrolled
22 Trials studying Coronary Artery Disease
17,223 Patients Enrolled for Coronary Artery Disease
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,837 Previous Clinical Trials
47,851,423 Total Patients Enrolled
165 Trials studying Coronary Artery Disease
268,828 Patients Enrolled for Coronary Artery Disease
Damini Dey, PhDPrincipal InvestigatorCedars-Sinai Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
WARRIOR Ancillary Study for CCTA Analysis
Damini Dey 2020. "WARRIOR Ancillary Study for CCTA Analysis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05035056.
~17 spots leftby Aug 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top